Ikarian Capital, LLC Fibrogen Inc Put Options Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $944,457 - $7.81 Million	379,300 New	379,300 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $1.97 Million - $5.16 Million	-193,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $1.97 Million - $3.79 Million	-106,200 Reduced 35.4%	193,800 $5.16 Million
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $1.49 Million - $2.68 Million	48,100 Added 19.09%	300,000 $10.4 Million
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $1.85 Million - $2.45 Million	50,000 Added 24.76%	251,900 $9.34 Million
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $4.93 Million - $5.55 Million	121,900 Added 152.38%	201,900 $8.3 Million
Q1 2020 May 15, 2020	BUY	$23.3 - $45.96 $1.86 Million - $3.68 Million	80,000 New	80,000 $2.78 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.